跳至主要内容
临床试验/NCT04998942
NCT04998942进行中(未招募)不适用

Virtual Cardiac Wellness Program Following Hypertensive Disorders of Pregnancy

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年8月11日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
100
试验地点
2
主要终点
Postpartum weight loss at 6 months postpartum

研究概览

简要总结

Hypertensive disorders of pregnancy (HDP) are now well-recognized risk factors for adverse outcomes in the postpartum period and for development of future cardiovascular disease (CVD). Postpartum BMI has emerged as a strong predictor of both short- and long-term blood pressure (BP) control in observational studies suggesting that earlier postpartum lifestyle modifications may be instrumental in future CVD risk reduction in women with HDP. While such lifestyle modifications are recognized as critical for postpartum health, implementation and engagement of postpartum women remains a challenge as new mothers face greater barriers to in-person care given childcare responsibilities. The proposed study will investigate the acceptability of a virtual cardiac wellness program and its impact on weight, lifestyle modifications, cardiometabolic health, patient engagement, and outcomes following HDP as compared to the standard of care for postpartum women at Massachusetts General Hospital.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Participant)

盲法说明

In order to enable us to conduct a placebo-controlled study, we will not disclose to participants which intervention they have been assigned to. In order to obtain blinded data, incomplete disclosure is necessary to make the research scientifically valid and feasible. Unblinding subjects increases the risk that a favorable outcome is associated with the intervention simply because subjects are aware that they received an intervention and thus performing a placebo-controlled trial is necessary to determine the true effect of the intervention.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with a diagnosis of HDP inclusive of gestational hypertension, preeclampsia, eclampsia, and chronic hypertension with superimposed preeclampsia
  • Pre-pregnancy BMI >18.5
  • Age ≥ 18 years
  • Access to a phone
  • Delivery at MGH and receive longitudinal obstetrics care at MGH

排除标准

  • Moderate or severe cognitive impairment
  • Current incarceration
  • Pre-pregnancy BMI ≤ 18.5
  • Women without a documented pre-natal weight or weight recorded 1 year prior to pregnancy
  • Baseline exercise of > 150 minutes/ week at the time of study enrollment
  • Not cleared for exercise by primary OB

结局指标

主要结局

Postpartum weight loss at 6 months postpartum

时间窗: 1 year

Postpartum weight loss (Last prenatal visit weight- weight at 6 months postpartum) as a proportion of weight gained during pregnancy (Last prenatal visit weight- either 1st prenatal weight or pre-pregnancy weight within 1 year)

次要结局

  • Change in stress as assessed by self-reported stress survey(6 months)
  • Change in self efficacy for physical activity assessed by questionnaire(6 months)
  • Change in cardiovascular disease knowledge assessed by American Heart Association Cardiovascular Disease Go Red Questionnaire(6 months)
  • Postpartum weight loss at 1 year postpartum(1 year)
  • Return to pre-pregnancy weight(1 year)
  • Changes in blood pressure(1 year)
  • Change in self efficacy for diet(6 months)
  • Change in sedentary time(6 months)
  • Change in physical activity as assessed by modified Duke Activity Status Index(6 months)
  • Change in quality of diet assessed by Dietary Approaches to Stop Hypertension (DASH) score(6 months)
  • Change in physical activity as assessed by self-reported physical activity survey(6 months)
  • Change in stress as assessed by American Heart Association Cardiovascular Disease Go Red Questionnaire(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amy A. Sarma, MD

Cardiologist

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验

Virtual Cardiac Wellness Program Following... | 临床试验